IRCT20220111053692N3招募中未知
Bioequivalence study of Metformin ER 500 mg tablet (Saponine Iran) versus Glucophage® XR 500 mg (Merck-Brand) Tablet in healthy volunteers
Saponine Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- Male
入选标准
- •18 to 50 years old
- •Weight in range of 10 % proper body weight
- •All volunteers should be in a good health condition on the basis of medical history, physical examination, routine blood test.
- •and possessing negative test for hepatitis B surface antigen (HBs-Ag), antihepatitis-C antibody (anti-HCV), and anti-HIV.
排除标准
- •Volunteers with hypersensitivity to Metformin were excluded.
- •those with known history of drug abuse. alcohol consumer or cigarette smokers.
- •Taking medications that have drug interactions with Metformin until one month before studying.
- •disinclination to take the test
- •Blood donation or blood loss of more than 200 ml in the past month
研究者
相似试验
尚未招募
Unknown
Bioequivalence study of Metformin 500mg tabletIRCT20200623047902N27Ronak Pharm company36
已完成
不适用
Bio equivalence study of metformin 500 mgIRCT20200513047423N1Sana Med24
招募中
不适用
In-vivo Bioequivalence Test of Metformin ER tablets1000 mg Kooshan Pharmed with brand drug (Glucophage® 1000 mg ER Tablet ,Merck Sharp & Dohme, German)Bio equivalence test.IRCT20200105046010N70Koushan Pharmed Pharmaceutical Company24
招募中
Unknown
Bioequivalence study of metformin 1000 mg tabletsIRCT20230222057495N14Jalinous Pharmaceutical Company24
尚未招募
不适用
Bioequivalance study of Metformin 1000 mg TabletsBioequivalance Metformin 1000 mg.IRCT20200513047423N8Sana Med24